Zimmer Partners’s Acutus Medical Inc AFIB Stock Holding History

Zimmer Partners’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,000	Closed	-$298K	–	177
2020 Q3	$298K	Buy	+10,000	New	+$304K	﹤0.01%	115

Other funds holding AFIB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Zimmer Partners's AFIB Position: Q4 2020 in Review

Zimmer Partners sold out of Acutus Medical Inc (AFIB) in Q4 2020, closing a stake of 10,000 shares — an estimated $298K sold.

Zimmer Partners first reported a position in AFIB in Q3 2020 and held it in 1 quarter. The position peaked at $298K in Q3 2020. 65 funds tracked by Wall St. Rank hold AFIB as of Q4 2020.

Zimmer Partners reported no remaining Acutus Medical Inc position as of Q4 2020 after selling out during the quarter.
Zimmer Partners sold 10,000 Acutus Medical Inc shares in Q4 2020, an estimated $298K.
Zimmer Partners first reported a position in Acutus Medical Inc in Q3 2020 and held it in 1 quarter.
Zimmer Partners's Acutus Medical Inc position peaked at $298K in Q3 2020.
65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2020.

Based on Zimmer Partners's 13F filing for Q4 2020, filed 16 Feb 2021.